FDA Inspection
Allergan Sales, LLC dba Bioscience LaboratoriesAllergan Sales, LLC dba Bioscience Laboratories – FDA Inspection, Sep 6, 2013
Record Details
This FDA Inspection record concerns Allergan Sales, LLC dba Bioscience Laboratories, with an inspection on September 6, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 6, 2013
- Product Type
- Drugs
View Company Profile
ID · 1aeff3bc-f6f4-43f8-9933-7f9e41196bfe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 847049
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Allergan Sales, LLC dba Bioscience Laboratories
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 5, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Sales, LLC dba Bioscience Laboratories
- FDA Inspection 1249057 - 2024-09-03
- FDA Inspection 1022550 - 2017-02-01
- FDA Inspection 921178 - 2015-04-20
- FDA Inspection 650340 - 2010-03-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.